CellsNeurosciencePeer-reviewed journal article
Combined Transplantation of Mesenchymal Progenitor and Neural Stem Cells to repair cervical spinal cord injury.
Seok Voon White, Yee Hang Ethan MaiD, Christine D. Plant, Alan R. HarveyiD, Giles W. PlantiD
Abstract
Mesenchymal progenitor cells (MPC) are effective in reducing tissue loss, preserving white matter and improving forelimb function after spinal cord injury (SCI) (White et al., 2016). We proposed that by preconditioning the mouse by intravenous delivery (IV) of MPCs for 24 hours following SCI that this would provide a more favorable tissue milieu for NSC intraspinal bridging transplantation at day 3 and day 7. In com-bination these transplants will provide better anatomical and functional outcomes. The intravenous MSCs would provide cell protection and reduce inflammation. NSCs would provide a tissue bridge for axonal regeneration and myelination and reconnect long tract spinal pathways. Results showed that initial protection of the injury site by IV MPCs transplantation resulted in no increased survival of the NSCs transplanted at Day 7. However, integration of transplanted NSCs was increased at the Day 3 time point indicating MPCs influence very early immune signaling. We show in this study that MPC transplantation resulted in a co-operative NSC cell survival improvement at Day 3 post SCI. In addition to increased NSC survival at day 3 there was an increase in NSC derived mature oligodendrocytes at this early time point. In vitro analysis confirmed MPC driven oligodendrocyte differentiation which was statistically increased when compared to control NSC only cultures. These observations provide important information about the combination, delivery, and timing of two cellular therapies in treating SCI. This study provides important new data on understanding the MPC inflammatory signaling within the host tissue and time points for cellular transplantation survival and oligodendroglia differentiation. These results demonstrate that MPC transplantation can alter the therapeutic window for intraspinal transplantation by controlling both the circulating inflammatory response and local tissue milieu.
- Citations
- 6
- FWCI
- 3.96
- Field percentile
- top 7%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Prolonged Heat Treated Mesenchymal Precursor Cells Induce Positive Outcomes Following Transplantation in Cervical Spinal Cord Injury.
Seok Voon White, Yee Hang Ethan Ma, … Giles W. Plant·CellsPeer-reviewed·Sep 23, 2025
- Analysis of astrocyte progenitors derived from human induced pluripotent stem cells in vitro and following transplantation into the intact spinal cord.
Alessia Niceforo, Ying Jin, … Itzhak Fischer·bioRxiv·Jun 27, 2025
- Transplanted Autologous Neural Stem Cells Show Promise in Restoring Motor Function in Monkey Spinal Cord Injury
Razieh Jaberi, Reza Jabbari, … Sahar Kiani·bioRxiv·May 6, 2023
- Injectable hydrogel embedded with mesenchymal stem cells repairs severe spinal cord injury
- Comparative Neuroprotective Effects of Minocycline and Bone Marrow Mononuclear Cells After Complete Spinal Cord Transection in Adult Rats
Michelle Castro da Silva Holanda, Celice Cordeiro de Souza Bergh Pereira, … Walace Gomes‐Leal·bioRxiv·Feb 17, 2026
- Functional recovery by transplantation of human iPSC-derived A2B5 positive neural progenitor cell after spinal cord injury in mice
Yiyan Zheng, Xiaohui Chen, … Qilin Cao·International Journal of Molecular SciencesPeer-reviewed·Sep 13, 2025